S100B and NSE serum concentrations in Machado Joseph disease

Clinica Chimica Acta

Volumn 351, Issue 1-2, 2005, Pages 143-148

  Tort, Adriano B L ^a   Portela, Luis V C ^a   Rockenbach, Isabel C ^a   Monte, Thais L ^b   Pereira, Maria L ^a,b   Souza, Diogo O ^a   Rieder, Carlos R M ^b   Jardim, Laura B ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Brain markers; Machado Joseph disease; NSE; S100B

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC VALUE; DISABILITY; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; MACHADO JOSEPH DISEASE; MALE; NUCLEOTIDE REPEAT; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE;

ADULT; BIOLOGICAL MARKERS; DISABILITY EVALUATION; FEMALE; HUMANS; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROPSYCHOLOGICAL TESTS; PHOSPHOPYRUVATE HYDRATASE; REPETITIVE SEQUENCES, AMINO ACID; S100 PROTEINS;

EID: 9444288079     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.08.010     Document Type: Article

References (30)

1. K.K. Nakano, D.M. Dawson, and A. Spence Machado disease. A hereditary ataxia in Portuguese emigrants to Massachussetts Neurology 22 1972 49
2. B.T. Woods, and H.H. Schaumburg Nigro-spino-dentatal degeneration with nuclear ophtalmoplegia. A unique and partially treatable clinico-pathological entity J. Neurol. Sci. 17 1972 149 166
3. R.N. Rosenberg, W.L. Nyhan, C. Bay, and P. Shore Autosomal dominant striatonigral degeneration Neurology 26 1976 703 714
4. Y. Takiyama, M. Nishizawa, H. Tanaka, S. Kawashima, H. Sakamoto, and Y. Karube The gene for Machado-Joseph disease maps to human chromosome 14q Nat. Genet. 4 1993 300 303
5. Y. Kawaguchi, T. Okamoto, M. Taniwaki, M. Aizawa, M. Inoue, and S. Katayama CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 Nat. Genet. 8 1994 221 228
6. Y. Takiyama, K. Sakoe, I. Nakano, and M. Nishizawa Machado-Joseph disease: cerebellar ataxia and autonomic dysfunction in a patient with the shortest known expanded allele (56 CAG repeat units) of the MJD1 gene Neurology 49 1997 604 606
7. G. Stevanin, A. Dürr, and A. Brice Clinical and molecular advances in autosomal dominat cerebellar ataxias: from genotype to phenotype and physiopathology Eur. J. Hum. Genet. 8 2000 14 18
8. L.B. Jardim, M.L. Pereira, I. Silveira, A. Ferro, J. Sequeiros, and R. Giugliani Machado-Joseph disease in South Brazil: clinical and molecular characterization of kindreds Acta Neurol. Scand. 104 2001 224 231
9. J. Sequeiros, and P. Coutinho Epidemiology and clinical aspects of Machado-Joseph disease Adv. Neurol. 61 1993 139 153
10. n Arch. Neurol. 58 2001 899 904
11. R.N. Rosenberg Machado-Joseph disease: an autosomal dominant motor system degeneration Mov. Disord. 7 1992 193 203
12. P. Coutinho, A. Guimaraes, and F. Scaravilli The pathology of Machado-Joseph disease. Report of a possible homozygous case Acta Neuropathol. (Berl.) 58 1982 48 54
13. J. Sequeiros, and P. Coutinho Epidemiology and clinical aspects of Machado-Joseph disease A.E. Harding T. Deufel Inherited Ataxia Advances in Neurology vol. 61 1993 Raven Press NewYork 139 153
14. R. Donato Intracellular and extracellular roles of S100 proteins Microsc. Res. Tech. 60 2003 540 551
15. P.E. Vos, K.J. Lamers, J.C. Hendriks, M. van Haaren, T. Beems, and C. Zimmerman Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury Neurology 621 2004 303 310
16. C. Foerch, B. Otto, O.C. Singer, T. Neumann-Haefelin, B. Yan, and J. Berkefeld Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion Stroke 2004
17. A. Petzold, R. Jenkins, H.C. Watt, A.J. Green, E.J. Thompson, and G. Keir Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease Neurosci. Lett. 336 2003 167 170
18. M. Rothermundt, G. Ponath, T. Glaser, G. Hetzel, and V. Arolt S100B serum concentrations and long-term improvement of negative symptoms in patients with schizophrenia Neuropsychopharmacology 29 2004 1004 1011
19. R. Walz, L.V. Portela, A.B. Tort, E.C. Neto, L.N. Fernandes, and C.A. Goncalves Serum S100B concentrations in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis Neurology 54 2000 2021 2022
20. L.V. Portela, J.C. Brenol, R. Walz, M. Bianchin, A.B. Tort, and U.P. Canabarro Serum S100B concentrations in patients with lupus erythematosus: preliminary observation Clin. Diagn. Lab. Immunol. 9 2002 164 166
21. U.E. Pleines, M.C. Morganti-Kossmann, M. Rancan, H. Joller, O. Trentz, and T. Kossmann S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury J. Neurotrauma 18 2001 491 498
22. M. Herrmann, and H. Ehrenreich Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring Restor. Neurol. Neurosci. 21 2003 177 190
23. T. Buttner, B. Lack, M. Jager, W. Wunsche, W. Kuhn, and T. Muller Serum concentrations of neuron-specific enolase and s-100 protein after single tonic-clonic seizures J. Neurol. 246 1999 459 461
24. I. Silveira, P. Coutinho, P. Maciel, C. Gaspar, S. Hayes, and A. Dias Molecular genetic studies in spinocerebellar ataxias: analysis of SCA1, DRPLA and MJD mutations in patients from 48 Portuguese ataxia families Am. J. Med. Genet. (Neuropsychiat. Genet.) 81 1998 134 138
25. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
26. Fahn S, Elton R. Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent Developments in Parkinson's Disease, vol. 2. Florham Park, NJ. Macmillan Health Care Information; 1987 p.153-163, p.293-304.
27. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br. J. Psychiatry 194 1979 382 389
28. L.V. Portela, A.B. Tort, D.V. Schaf, L. Ribeiro, D.B. Nora, and R. Walz The serum S100B concentration is age dependent Clin. Chem. 48 2002 950 952
29. D.R. Lara, C.S. Gama, P. Belmonte-de-Abreu, L.V. Portela, C.A. Goncalves, and M. Fonseca Increased serum S100B protein in schizophrenia: a study in medication-free patients Psychiatr. Res. 35 2001 11 14
30. E.R. Peskind, W.S. Griffin, K.T. Akama, M.A. Raskind, and L.J. Van Eldik Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease Neurochem. Int. 39 2001 409 413